Table 2.
ARFI-Monitored Hemostatic Challenge Bleeding Rates & Times to Hemostasis by Dog Phenotype.
| Hemostasis Phenotype Dog Genotype | n | Mean Bleeding Rate (mm2/min) | Mean Time to Hemostasis (min)* |
|---|---|---|---|
| Normal Hemostasis | |||
| 1. Normal | 6 | 0.62 ± 0.33# | 17.52 ± 6.05§ |
| Abnormal Secondary Hemostasis | |||
| 2. Naïve Hemophilia A | 8 | 0.86 ± 0.34# | >30§ |
| 3. Hemophilia A+FVIII to 11.3 ± 1.8% of normal | 8 | 0.61 ± 0.30# | 28.40 ± 12.39§ |
| 4. Hemophilia A expressing FVIIa at 1.3 – 2 μg/ml [37] | 3† | 0.62 ± 0.29# | 26.09 ± 5.58§ |
| Abnormal Primary Hemostasis | |||
| 5. Naïve VWD | 6 | 1.72 ± 0.43# | 23.98 ± 9.90§ |
| 6. VWD+VWF to 7.1 ± 1.7% of normal VWF:Ag | 4 | 0.47 ± 0.35# | 14.64 ± 9.32§ |
ARFI Time to Hemostasis is defined as that required to bleed 75% of the total detected area of hemorrhage.
Mean from two separate procedures on each dog. No additional plasma therapy was required in these dogs.
Mean Bleeding Rate comparisons 1 vs 2 p<0.111, 1 vs 3 p<0.520, 1 vs 4 p<0.492, 1 vs 5 p<0.00003, 1 vs 6 p = 0.523, 5 vs 6 p = 0.00024.
Time to Hemostasis comparisons 1 vs 2 p<0.00078, 1 vs 3 p<0.027, 1 vs 4 p<0.057, 2 vs 4 p<0.01, 1 vs 5 p = 0.166, 1 vs 6 p = 0.566, 5 vs 6 p = 0.137.